Baxter Cefazolin in Dextrose Injection
Recalled by Baxter International Inc.
Drug recall
Baxter International Inc.
Classification pending
The agency has not yet assigned a severity class to this recall. Classification usually follows the initial announcement by several weeks — check the official notice for the latest status.
Baxter International Inc. has recalled Baxter Cefazolin in Dextrose Injection, according to the U.S. Food and Drug Administration (FDA). The recall was announced on July 24, 2026. The FDA has not yet assigned it a severity classification — that usually follows the initial announcement by several weeks.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Baxter Cefazolin in Dextrose Injection. The company behind the recall is Baxter International Inc.. The FDA describes the product as: “Baxter Cefazolin in Dextrose Injection”
Why was Baxter Cefazolin in Dextrose Injection recalled?
According to the FDA, the stated reason for the recall is: “Particulate matter identified as cardboard was found in the solution. Cefazolin is an antibiotic given by IV, and foreign material in an intravenous solution can pose a risk to patients.” In plain terms, this recall relates to foreign material.
A foreign material recall means that pieces of something which should not be in food — such as metal, plastic, or glass — may be present. These can pose a choking hazard or cause injury. Recalls like these are issued to remove the affected product before anyone is hurt.
What should you do?
If you think you may have bought Baxter Cefazolin in Dextrose Injection, compare it against the product description and identifying codes (Hospital and clinic pharmacies should verify affected lot numbers against the official Baxter notice. Patients receiving this antibiotic should direct question…) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Baxter International Inc. or your local health authority.
About this recall
This recall was distributed in United States. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Who this recall affects
This recall matters to anyone who bought Baxter Cefazolin in Dextrose Injection. Even if you feel fine, it's worth checking what you have on hand rather than assuming you were missed.
Distribution listed in the notice: United States.
What foreign material actually means
A foreign material recall means that pieces of something which should not be in food — such as metal, plastic, or glass — may be present. These can pose a choking hazard or cause injury. Recalls like these are issued to remove the affected product before anyone is hurt.
In this case, the concern applies specifically to Baxter Cefazolin in Dextrose Injection from Baxter International Inc. — not to the wider category of products. Similar items from other brands aren't part of this recall.
How to check whether you have it
On medicine bottles, the lot number and expiration date are printed on the pharmacy label or stamped directly on the manufacturer's bottle — often near the bottom edge or on the back. If a pharmacy label covers it, your pharmacist can look up the lot they dispensed.
Compare what you find against the identifying details in this recall: Hospital and clinic pharmacies should verify affected lot numbers against the official Baxter notice. Patients receiving this antibiotic should direct questions to their care team.
What to do if you already bought it
Do not stop taking a prescribed medicine on your own because of a recall — for many conditions, an interrupted dose carries its own risk.
Instead, check the lot number against the details above and contact your pharmacist, who can confirm what they dispensed and arrange a replacement.
If you've had an unexpected reaction, contact your healthcare provider. Problems can also be reported to the FDA's MedWatch program.
Full recall details
- Status
- Ongoing
- Date reported
- July 24, 2026
- Distributed in
- United States
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Baxter Cefazolin in Dextrose Injection recalled?+
According to the FDA: Particulate matter identified as cardboard was found in the solution.
How serious is this recall?+
Classification pending. The agency has not yet assigned a severity class to this recall. Classification usually follows the initial announcement by several weeks — check the official notice for the latest status.
What should I do if I have Baxter Cefazolin in Dextrose Injection?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: FDA-PR-CEFAZOLIN-2026. Information last synced from the FDA on July 31, 2026.